Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
49
DR.TO Quote, Financials, Valuation and Earnings
Last price:
$15.42
Seasonality move
:
6.27%
Day range:
$15.33 - $15.48
52-week range:
$13.59 - $17.97
Dividend yield:
2.34%
P/E ratio:
2.20x
P/S ratio:
0.96x
P/B ratio:
2.36x
Volume:
20.9K
Avg. volume:
20K
1-year change:
-1.6%
Market cap:
$282.9M
Revenue:
$454.2M
EPS (TTM):
$7.01
Analysts' Opinion
-
Consensus RatingMedical Facilities Corp. has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $16.40, Medical Facilities Corp. has an estimated upside of 5.34% from its current price of $15.42.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $15.84 representing 100% downside risk from its current price of $15.42.
Fair Value
-
According to the consensus of 2 analysts, Medical Facilities Corp. has 5.34% upside to fair value with a price target of $16.40 per share.
DR.TO vs. S&P 500
-
Over the past 5 trading days, Medical Facilities Corp. has underperformed the S&P 500 by -3.73% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Medical Facilities Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Medical Facilities Corp. has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Medical Facilities Corp. reported revenues of $113.7M.
Earnings Growth
-
Medical Facilities Corp. has grown year-over-year earnings for 5 quarters straight. In the most recent quarter Medical Facilities Corp. reported earnings per share of $0.51.
Enterprise value:
341.6M
EV / Invested capital:
1.40x
Price / LTM sales:
0.96x
EV / EBIT:
8.08x
EV / Revenue:
0.95x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
5.00x
Price / Operating cash flow:
5.08x
Enterprise value / EBITDA:
5.48x
Gross Profit (TTM):
$112.9M
Return On Assets:
18.41%
Net Income Margin (TTM):
21.66%
Return On Equity:
48.45%
Return On Invested Capital:
29.36%
Operating Margin:
14.74%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $597.2M | $493.6M | $360M | $104.8M | $113.7M | |
| Gross Profit | $185.6M | $168M | $112.9M | $33.8M | $36.8M | |
| Operating Income | $86.2M | $82.5M | $42.3M | $12.9M | $16.8M | |
| EBITDA | $115.7M | $106.3M | $62.3M | $18.6M | $22.1M | |
| Diluted EPS | $0.28 | $1.09 | $7.01 | $0.42 | $0.51 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $182M | $173M | $130.5M | $115.8M | $135.6M | |
| Total Assets | $563.7M | $550.3M | $476.9M | $447.8M | $375M | |
| Current Liabilities | $112.8M | $96M | $112.7M | $100.4M | $75.7M | |
| Total Liabilities | $346.9M | $329.8M | $331.2M | $296.5M | $221.8M | |
| Total Equity | $216.8M | $220.5M | $145.7M | $151.3M | $153.2M | |
| Total Debt | $190.2M | $175.4M | $172.2M | $131.6M | $90.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $94.9M | $110.3M | $74.2M | $30M | $19.3M | |
| Cash From Investing | -$20.2M | -$9.9M | $120.8M | -$619.5K | -$1.5M | |
| Cash From Financing | -$97.9M | -$111.7M | -$158M | -$28.4M | -$20.2M | |
| Free Cash Flow | $70.3M | $100.4M | $68.3M | $29.4M | $17.8M | |
DR.TO
Sector
Market Cap
$282.9M
$27.9M
Price % of 52-Week High
85.81%
51.04%
Dividend Yield
2.34%
0%
Shareholder Yield
40.73%
-1.49%
1-Year Price Total Return
-1.6%
-16.66%
Beta (5-Year)
0.241
0.516
Dividend yield:
2.34%
Annualized payout:
$0.35
Payout ratio:
14.95%
Growth streak:
1 years
Technicals
8-day SMA
Sell
Level
$15.64
200-day SMA
Buy
Level
$15.16
Bollinger Bands (100)
Buy
Level
14.15 - 15.35
Chaikin Money Flow
Sell
Level
-1.2M
20-day SMA
Sell
Level
$15.79
Relative Strength Index (RSI14)
Sell
Level
49.52
ADX Line
Sell
Level
21.64
Williams %R
Buy
Level
-84.2105
50-day SMA
Buy
Level
$14.94
MACD (12, 26)
Buy
Level
0.16
25-day Aroon Oscillator
Buy
Level
36
On Balance Volume
Sell
Level
-2.3M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.6124)
Sell
CA Score
(Annual)
Level (-0.3543)
Buy
Beneish M-Score
(Annual)
Level (-3.4638)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-0.1409)
Buy
Piotroski F Score
(Annual)
Level (9)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Medical Facilities Corp. engages in the provision of surgical hospitals and an ambulatory surgery center. Its facilities include Arkansas Surgical Hospital, Unity Medical and Surgical Hospital, Black Hills Surgical Hospital, Newport Center Surgical, City Place Surgery Center, and Two Rivers Surgical Center. The company was founded on January 12, 2004 and is headquartered in Toronto, Canada.
Stock Forecast FAQ
In the current month, DR.TO has received 0 Buy ratings 2 Hold ratings, and 0 Sell ratings. The DR.TO average analyst price target in the past 3 months is $16.40.
-
Where Will Medical Facilities Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Medical Facilities Corp. share price will rise to $16.40 per share over the next 12 months.
-
What Do Analysts Say About Medical Facilities Corp.?
Analysts are divided on their view about Medical Facilities Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Medical Facilities Corp. is a Sell and believe this share price will drop from its current level to $15.84.
-
What Is Medical Facilities Corp.'s Price Target?
The price target for Medical Facilities Corp. over the next 1-year time period is forecast to be $16.40 according to 2 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is DR.TO A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Medical Facilities Corp. is a Hold. 2 of 2 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of DR.TO?
You can purchase shares of Medical Facilities Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Medical Facilities Corp. shares.
-
What Is The Medical Facilities Corp. Share Price Today?
Medical Facilities Corp. was last trading at $15.42 per share. This represents the most recent stock quote for Medical Facilities Corp.. Yesterday, Medical Facilities Corp. closed at $15.42 per share.
-
How To Buy Medical Facilities Corp. Stock Online?
In order to purchase Medical Facilities Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get DR.TO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
DR.TO
Sector
P/E ratio
2.20x
23.85x
PEG ratio
0.00x
-0.01x
P/B ratio
2.36x
1.81x
Price / LTM sales
0.96x
1.58x
Growth Metrics
DR.TO
Sector
Revenue growth
8.52%
4.62%
Earnings growth
22.01%
10.7%
Revenue (5-year growth)
-2.98%
6.5%
Earnings forecast
$0.34
-$0.21
Profitability
DR.TO
Sector
Profitability FY 2024
$154.3M
$3.6M
Return on invested capital
29.36%
-31.87%
Return on assets
18.41%
-28.18%
Return on equity
48.45%
-37.63%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Mar
12
Estimated Next Earnings Date
Feb
5
Balance Sheet
DR.TO
Sector
Total cash
$65.1M
$26.4M
Short term investments
--
$25.7M
Total assets
$498M
$76.9M
Long term debt
$90.6M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 20
Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.
Buy
54
BMRN alert for Dec 20
BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.
Buy
82
RKLB alert for Dec 20
Rocket Lab Corp. [RKLB] is up 17.72% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
